The DCGI has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use among children aged 12 to 18 years. Covaxin will be administered among children in two doses, with a gap of 28 days between the first and second dose. In October, the Subject Expert Committee (SEC) had recommended the DCGI to allow emergency use of Covaxin among children.
The DCGI has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use among children aged 12 to 18 years. Covaxin will be administered among children in two doses, with a gap of 28 days between the first and second dose. In October, the Subject Expert Committee (SEC) had recommended the DCGI to allow emergency use of Covaxin among children.
